(Total Views: 645)
Posted On: 11/10/2020 12:13:39 PM
Post# of 153986
Last post as this price drop has made me crawl out from my daily duties - For those harping on NP for not pursuing m/m due to FDA suggestion - with limited resources (financial & personnel) you go for the slam dunk , not the 3-pointer from deep.
Most M/M I believe do not progress to S/C. My guess is it would have been harder to enroll as we'd be competing with a wider range of therapies and the idea that someone may just get better on their own and not want an experimental treatment over a steroid, etc.
S/C is the slam dunk here and DSMC has virtually said as much by adding another interim, no change to trial, and putting in the 42-day metric. We are in a class of our own as opposed to dealing w/ LLY MAB in M/M now (amongst many others)...LLY was already kicked out of our class along with several others in the past.
This is the highest probability path to approval w/ the least resources imo. I don't fault NP at all for going this route. The LLY MAB approval for M/M only furthers my sentiment.
And, fwiw, daytrading can be very lonely in its success, I'm well aware of it firsthand, so I understand the desire to share the wins (and not wanting to share the losses), but probably best to do that on a diff. board and leave this board to the analysis of the facts impacting CYDY and less back/forth TA & pats on back. Best of luck to traders & investors alike!
Most M/M I believe do not progress to S/C. My guess is it would have been harder to enroll as we'd be competing with a wider range of therapies and the idea that someone may just get better on their own and not want an experimental treatment over a steroid, etc.
S/C is the slam dunk here and DSMC has virtually said as much by adding another interim, no change to trial, and putting in the 42-day metric. We are in a class of our own as opposed to dealing w/ LLY MAB in M/M now (amongst many others)...LLY was already kicked out of our class along with several others in the past.
This is the highest probability path to approval w/ the least resources imo. I don't fault NP at all for going this route. The LLY MAB approval for M/M only furthers my sentiment.
And, fwiw, daytrading can be very lonely in its success, I'm well aware of it firsthand, so I understand the desire to share the wins (and not wanting to share the losses), but probably best to do that on a diff. board and leave this board to the analysis of the facts impacting CYDY and less back/forth TA & pats on back. Best of luck to traders & investors alike!
(14)
(1)
